Looking to Advance New Drugs to the Clinic, UChicago Spinout Pyxis Files for $100M IPO

The University of Chicago spinout Pyxis Oncology has filed for an initial public offering (IPO) after earlier this year signing a worldwide licensing agreement with Pfizer and raising $152 million…

Evelo Bioscience, a Biotech Company Based on UChicago-licensed Technology, Debuts on Nasdaq

Evelo is dedicated to improving the lives of patients globally through the development of a new modality of medicines called monoclonal microbials

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.

Accept